Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Issay Kitabayashi

Showing results (71-80 of 85) with videos related to

Pageof 9
Sort By:
Stem Cell Reports|February 15, 2014
The TIF1β-HP1 system maintains transcriptional integrity of hematopoietic stem cellsSatoru Miyagi, Shuhei Koide, Atsunori Saraya, et al.
Experimental Hematology|November 26, 2013
The BALB/c-specific polymorphic SIRPA enhances its affinity for human CD47, inhibiting phagocytosis against human cells to promote xenogeneic engraftmentChika Iwamoto, Katsuto Takenaka, Shingo Urata, et al.
Cancer Science|April 1, 2021
CDKN1C-mediated growth inhibition by an EZH1/2 dual inhibitor overcomes resistance of mantle cell lymphoma to ibrutinibYuki Kagiyama, Shuhei Fujita, Yutaka Shima, et al.
Molecular and Cellular Biology|July 12, 2017
EPC1/TIP60-Mediated Histone Acetylation Facilitates Spermiogenesis in MiceYixin Dong, Kyo-Ichi Isono, Kazuyuki Ohbo, et al.
Stem Cells (Dayton, Ohio)|January 30, 2016
A Synthetic Polymer Scaffold Reveals the Self-Maintenance Strategies of Rat Glioma Stem Cells by Organization of the Advantageous NicheKouichi Tabu, Nozomi Muramatsu, Christian Mangani, et al.
Blood Advances|April 5, 2019
NUP98-HBO1-fusion generates phenotypically and genetically relevant chronic myelomonocytic leukemia pathogenesisYoshihiro Hayashi, Yuka Harada, Yuki Kagiyama, et al.
Cancer Science|October 22, 2018
Dual inhibition of enhancer of zeste homolog 1/2 overactivates WNT signaling to deplete cancer stem cells in multiple myelomaMakoto Nakagawa, Shuhei Fujita, Takuo Katsumoto, et al.
Acta Neuropathologica|February 12, 2026
Long-term administration of the mutant IDH inhibitor DS-1001b suppresses the growth of IDH1-mutant glioma in vitro and in mouse xenograft models and alters epigenetic profilesKenji Fujimoto, Mai Honda-Kitahara, Naoko Hattori, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 27, 2013
PML mediates glioblastoma resistance to mammalian target of rapamycin (mTOR)-targeted therapiesAkio Iwanami, Beatrice Gini, Ciro Zanca, et al.
Molecular Cancer Therapeutics|November 16, 2019
A Potent Blood-Brain Barrier-Permeable Mutant IDH1 Inhibitor Suppresses the Growth of Glioblastoma with IDH1 Mutation in a Patient-Derived Orthotopic Xenograft ModelYukino Machida, Makoto Nakagawa, Hironori Matsunaga, et al.
Pageof 9

Showing results (71-80 of 85) with videos related to

Sort By:
Pageof 9
Stem Cell Reports|February 15, 2014
The TIF1β-HP1 system maintains transcriptional integrity of hematopoietic stem cellsSatoru Miyagi, Shuhei Koide, Atsunori Saraya, et al.
Experimental Hematology|November 26, 2013
The BALB/c-specific polymorphic SIRPA enhances its affinity for human CD47, inhibiting phagocytosis against human cells to promote xenogeneic engraftmentChika Iwamoto, Katsuto Takenaka, Shingo Urata, et al.
Cancer Science|April 1, 2021
CDKN1C-mediated growth inhibition by an EZH1/2 dual inhibitor overcomes resistance of mantle cell lymphoma to ibrutinibYuki Kagiyama, Shuhei Fujita, Yutaka Shima, et al.
Molecular and Cellular Biology|July 12, 2017
EPC1/TIP60-Mediated Histone Acetylation Facilitates Spermiogenesis in MiceYixin Dong, Kyo-Ichi Isono, Kazuyuki Ohbo, et al.
Stem Cells (Dayton, Ohio)|January 30, 2016
A Synthetic Polymer Scaffold Reveals the Self-Maintenance Strategies of Rat Glioma Stem Cells by Organization of the Advantageous NicheKouichi Tabu, Nozomi Muramatsu, Christian Mangani, et al.
Blood Advances|April 5, 2019
NUP98-HBO1-fusion generates phenotypically and genetically relevant chronic myelomonocytic leukemia pathogenesisYoshihiro Hayashi, Yuka Harada, Yuki Kagiyama, et al.
Cancer Science|October 22, 2018
Dual inhibition of enhancer of zeste homolog 1/2 overactivates WNT signaling to deplete cancer stem cells in multiple myelomaMakoto Nakagawa, Shuhei Fujita, Takuo Katsumoto, et al.
Acta Neuropathologica|February 12, 2026
Long-term administration of the mutant IDH inhibitor DS-1001b suppresses the growth of IDH1-mutant glioma in vitro and in mouse xenograft models and alters epigenetic profilesKenji Fujimoto, Mai Honda-Kitahara, Naoko Hattori, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 27, 2013
PML mediates glioblastoma resistance to mammalian target of rapamycin (mTOR)-targeted therapiesAkio Iwanami, Beatrice Gini, Ciro Zanca, et al.
Molecular Cancer Therapeutics|November 16, 2019
A Potent Blood-Brain Barrier-Permeable Mutant IDH1 Inhibitor Suppresses the Growth of Glioblastoma with IDH1 Mutation in a Patient-Derived Orthotopic Xenograft ModelYukino Machida, Makoto Nakagawa, Hironori Matsunaga, et al.
Pageof 9